Dr. Manmeet Ahluwalia serves as chief of medical oncology, chief scientific officer and deputy director of Miami Cancer Institute (MCI) since 2021, where he holds the Fernandez Family Foundation Endowed Chair in Cancer Research. Dr. Ahluwalia is a professor of translational medicine at Florida International University's Herbert Wertheim College of Medicine and serves as medical staff of Memorial Hospital for Cancer and Allied Diseases, Memorial Sloan Kettering Cancer Center (MSKCC) in New York. He received his medical degree from Maulana Azad Medical College, University of Delhi in 2000. He did his Internal Medicine residency at Cleveland Clinic Health System, Cleveland, OH followed by hematology and oncology fellowships at Roswell Park Center Institute. He has an established track record mentoring medical students, residents and fellows during his career at Cleveland Clinic and now at MCI. He has a master’s degree in business administration from the Weatherhead School of Business from the Case Western Reserve University.

Dr. Ahluwalia’s research is focused on the development of novel treatment approaches for patients with brain tumors and brain metastases. As a leader in neuro-oncology, he has spearheaded clinical research and secured significant NIH grants, including two RO1 grants as co-principal investigator and serves as the clinical trial leader on PO1 grants with over 10 million in funding. He has published 275 peer reviewed publications, with over 19,000 citations and has an H-index of 67.

Dr. Ahluwalia has been the recipient of multiple awards including Crain’s 40 under 40, ASCO Leadership Development Program Award, Career Development Award of National Cancer Institute, Most Distinguished Physician Award, American Association of Physicians of Indian Origin, Fellow of the American Society of Clinical Oncology, (FASCO) the inaugural Oncology Icon Awardand Ellis Island Medal of Honor underscoring his significant contributions to the field.